Dalton James Surmeier, Jr

Title: Dalton James Surmeier, Jr.: Innovator in Neurological Treatments

Introduction

Dalton James Surmeier, Jr. is a notable inventor based in Chicago, IL, whose contributions to the field of neurological disorders have garnered attention. With a total of five patents to his name, Surmeier's work encompasses innovative compositions and methods aimed at improving the lives of individuals suffering from various neurological conditions.

Latest Patents

Among his significant inventions is a patent for dihydropyridine compositions and methods for treating neurological disorders. This invention provides extended or sustained-release formulations of a dihydropyridine calcium channel blocker, specifically isradipine. The method aims to enhance treatment outcomes by maintaining sustained plasma levels of the calcium channel blocker.

Another critical patent addresses the formulation of compositions and methods to reduce pharmaceutical-induced toxicity. This invention is particularly vital as it seeks to mitigate toxicity associated with pharmaceutical treatments that may increase the risk of developing Parkinson's disease (PD) or exacerbate PD-related deterioration.

Career Highlights

Surmeier has made impactful strides in his career, having worked at prestigious institutions such as Northwestern University and Cavalon Therapeutics, Inc. His research focuses on devising innovative solutions to combat neurological disorders, and his advancements reflect a deep commitment to improving patient care.

Collaborations

Throughout his career, Surmeier has collaborated with prominent individuals in his field, including Richard B. Silverman and Garry Cooper. These partnerships have likely contributed significantly to the development and refinement of his groundbreaking inventions.

Conclusion

Dalton James Surmeier, Jr. stands as a pioneering figure in the landscape of neurological research and innovation. With a keen focus on developing effective treatments for complex disorders, his patents reveal a dedication to enhancing patient outcomes and advancing the field of neuroscience. The impact of his work continues to foster hope for individuals battling neurological challenges.